Special Edition: Therapeutic advances in multiple sclerosis
- PMID: 40651843
- PMCID: PMC12418458
- DOI: 10.1016/j.neurot.2025.e00697
Special Edition: Therapeutic advances in multiple sclerosis
References
-
- Scalfari A., Traboulsee A., Oh J., Airas L., Bittner S., Calabrese M., et al. Smouldering-associated worsening in multiple sclerosis: an international consensus statement on definition, biology, clinical implications, and future directions. Ann Neurol. 2024;96(5):826–845. - PubMed
-
- Goodin D.S. The epidemiology, pathology and pathogenesis of MS: therapeutic implications. Neurotherapeutics. 2025;4 xxxx. - PubMed
-
- Cohen B.A. Choosing initial MS therapy: personal, disease, and medication factors. Neurotherapeutics. 2025;4 xxxx. - PubMed
-
- Coyle P.K. Impact of sex on MS therapy. Neurotherapeutics. 2025;4 xxxx. - PubMed
-
- Yeh E.A., Aljomah J. Pediatric multiple sclerosis: improving outcome through high-efficacy therapies. Neurotherapeutics. 2025;4 xxxx. - PubMed
Publication types
LinkOut - more resources
Full Text Sources